Malcolm K. Brenner

Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

Helen E. Heslop, Catherine Y. Ng, Congfen Li et al. · Nature Medicine · 1996 · 833 citations

Life Sciences, Immunology, Infectious Diseases +13

Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease

Cliona M. Rooney, Susan K. Loftin, Martha Holladay et al. · British Journal of Haematology · 1995 · 244 citations

Medicine, Hematology, Pathology +16

Targeting of GD2-positive tumor cells by human T lymphocytes engineered to express chimeric T-cell receptor genes

Claudia Rössig, Catherine M. Bollard, Jed G. Nuchtern et al. · International Journal of Cancer · 2001 · 162 citations

Life Sciences, Immunology, Oncology +17

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma

B. Gahn, Fernando Siller-López, Angela D. Pirooz et al. · International Journal of Cancer · 2001 · 85 citations

Life Sciences, Immunology, Oncology +17

Interleukin-2 Gene-Modified Allogeneic Tumor Cells for Treatment of Relapsed Neuroblastoma

Laura C. Bowman, Michael E. Grossmann, Donna Rill et al. · Human Gene Therapy · 1998 · 78 citations

Life Sciences, Immunology, Oncology +17